Daniel Etcheverry

Daniel Etcheverry

Auto-generated profile, based on publicly available information

Daniel Etcheverry

Hospital General de Agudos JM Ramos Mejía, Ciudad Autónoma de Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

16 May 2025 in Revista Argentina de Cardiologia
Verified
Journal Article
Open access
PSPaola Settepassi
Paola Settepassi
SHSok Yoo Hyun
Sok Yoo Hyun
FMFlorencia Muschietti
Florencia Muschietti
DEDaniel Etcheverry
Daniel Etcheverry
HGHugo Garro
Hugo Garro
JCJusto Carbajales
Justo Carbajales
Background: Congenital long QT syndrome (LQTS) is an inherited channelopathy with a broad genetic spectrum but with a common phenotypic manifestation, the prolonged QT interval. However, its clinical presentation and natural history are highly variable. Objectives: The aim of this study was to define the genetic and clinical characteristics of patients with congenital LQTS during a long-term follow-up. Methods: Retrospective cohort study of patients with congenital LQTS genotype. The incidence of serious events at follow-up was defined. Quantitative variables are expressed as median and interquartile range (IQR) and qualitative variables as frequency and percentage. Results: Forty-four patients were included. Thirty percent of patients had LQTS1 genotype, 65% LQTS2 genotype and 5% LQTS3 genotype; 57% of cases carried the missense mutation, 11% the nonsense mutation and 32% the frameshift mutation. The corrected QT interval was 490 msec (IQR 462-498). The phenotype was present in 66% of patients, but it remained permanently only in 32%. Syncopal episodes occurred in 39% of patients. Cardiac arrest was the first manifestation in 7% of cases. Syncope recurred in 11% of patients even after pharmacological therapy, and 5% suffered sudden death. Seven patients received an implantable cardioverter-defibrillator (ICD). Among them, 29% received shocks due to ventricular tachycardia or ventricular fibrillation (VT/VF) and 58% presented device-related complications. Conclusions: Most patients had the LQTS1 or LQTS2 genotype, the intermittent phenotype, and a good response to treatment. Implantation at an early age and the high rate of complications during long-term follow-up require careful evaluation when indicating an ICD.

16 May 2025 in Revista Argentina de Cardiologia
Verified
Journal Article
Open access
PDF file
PSPaola Settepassi
Paola Settepassi
SHSok Yoo Hyun
Sok Yoo Hyun
FMFlorencia Muschietti
Florencia Muschietti
DEDaniel Etcheverry
Daniel Etcheverry
HGHugo Garro
Hugo Garro
JCJusto Carbajales
Justo Carbajales
Background: Congenital long QT syndrome (LQTS) is an inherited channelopathy with a broad genetic spectrum but with a common phenotypic manifestation, the prolonged QT interval. However, its clinical presentation and natural history are highly variable. Objectives: The aim of this study was to define the genetic and clinical characteristics of patients with congenital LQTS during a long-term follow-up. Methods: Retrospective cohort study of patients with congenital LQTS genotype. The incidence of serious events at follow-up was defined. Quantitative variables are expressed as median and interquartile range (IQR) and qualitative variables as frequency and percentage. Results: Forty-four patients were included. Thirty percent of patients had LQTS1 genotype, 65% LQTS2 genotype and 5% LQTS3 genotype; 57% of cases carried the missense mutation, 11% the nonsense mutation and 32% the frameshift mutation. The corrected QT interval was 490 msec (IQR 462-498). The phenotype was present in 66% of patients, but it remained permanently only in 32%. Syncopal episodes occurred in 39% of patients. Cardiac arrest was the first manifestation in 7% of cases. Syncope recurred in 11% of patients even after pharmacological therapy, and 5% suffered sudden death. Seven patients received an implantable cardioverter-defibrillator (ICD). Among them, 29% received shocks due to ventricular tachycardia or ventricular fibrillation (VT/VF) and 58% presented device-related complications. Conclusions: Most patients had the LQTS1 or LQTS2 genotype, the intermittent phenotype, and a good response to treatment. Implantation at an early age and the high rate of complications during long-term follow-up require careful evaluation when indicating an ICD.